Clinical Trial Update: "Thymalfasin Immunotherapy Study with Triple Regimen in Advanced MSS/pMMR Colorectal Cancer" [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study of thymosin alpha-1 immunotherapy combined with a triple regimen in advanced metastatic colorectal cancer; recruitment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Thymalfasin (thymosin alpha-1)

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: MCRC | Phase 2 | Status: RECRUITING